JAMP-Risperidone 0.25mg: Out of specification (Stability)
Brand(s)
Last updated
Summary
Product
JAMP-Risperidone 0.25mg
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| JAMP | JAMP-RISPERIDONE | DIN 02359529 | Tablet | Risperidone 0.25mg | ENN063001, ENN062001 |
Issue
The impurities are out of specification during stability in the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation
1310 Rue Nobel
Boucherville, Quebec
Canada
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Recall date
Identification number
RA-81247
Get notified
Receive emails about new and updated recall and safety alerts.